At baseline, FH non‐null and FH null groups did not differ in the expression levels of the LRPs (LRP5, LRP1) neither in the expression of scavenger receptors (MARCO, CD36) (Fig. S3). The gene discussed is MARCO; the disease is familial hyperaldosteronism.